VanEck Pharmaceutical Financial Statements From 2010 to 2024
| PPH Etf | USD 90.01 0.61 0.68% |
Check VanEck Pharmaceutical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among VanEck Pharmaceutical's main balance sheet or income statement drivers, such as , as well as many indicators such as . VanEck financial statements analysis is a perfect complement when working with VanEck Pharmaceutical Valuation or Volatility modules.
VanEck |
VanEck Pharmaceutical ETF ETF Price To Earning Analysis
VanEck Pharmaceutical's Price to Earnings ratio is typically used for current valuation of a company and is one of the most popular ratios that investors monitor daily. Holding a low PE stock is less risky because when a company's profitability falls, it is likely that earnings will also go down as well. In other words, if you start from a lower position, your downside risk is limited. There are also some investors who believe that low Price to Earnings ratio reflects the low pricing because a given company is in trouble. On the other hand, a higher PE ratio means that investors are paying more for each unit of profit.
Current VanEck Pharmaceutical Price To Earning | 17.83 X |
Most of VanEck Pharmaceutical's fundamental indicators, such as Price To Earning, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, VanEck Pharmaceutical ETF is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Generally speaking, the Price to Earnings ratio gives investors an idea of what the market is willing to pay for the company's current earnings.
| Competition |
Based on the latest financial disclosure, VanEck Pharmaceutical ETF has a Price To Earning of 17.83 times. This is much higher than that of the VanEck family and significantly higher than that of the Health category. The price to earning for all United States etfs is notably lower than that of the firm.
VanEck Pharmaceutical ETF Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining VanEck Pharmaceutical's current stock value. Our valuation model uses many indicators to compare VanEck Pharmaceutical value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across VanEck Pharmaceutical competition to find correlations between indicators driving VanEck Pharmaceutical's intrinsic value. More Info.VanEck Pharmaceutical ETF is rated number one ETF in price to earning as compared to similar ETFs. It also is rated number one ETF in price to book as compared to similar ETFs fabricating about 0.15 of Price To Book per Price To Earning. The ratio of Price To Earning to Price To Book for VanEck Pharmaceutical ETF is roughly 6.51 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the VanEck Pharmaceutical's earnings, one of the primary drivers of an investment's value.About VanEck Pharmaceutical Financial Statements
Investors use fundamental indicators, such as VanEck Pharmaceutical's revenue or net income, to determine how well the company is positioned to perform in the future. Although VanEck Pharmaceutical's investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
The fund normally invests at least 80 percent of its total assets in securities that comprise the funds benchmark index. Vaneck Pharmaceutical is traded on NASDAQ Exchange in the United States.
Currently Active Assets on Macroaxis
When determining whether VanEck Pharmaceutical ETF offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of VanEck Pharmaceutical's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Vaneck Pharmaceutical Etf. Outlined below are crucial reports that will aid in making a well-informed decision on Vaneck Pharmaceutical Etf:Check out the analysis of VanEck Pharmaceutical Correlation against competitors. You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.
The market value of VanEck Pharmaceutical ETF is measured differently than its book value, which is the value of VanEck that is recorded on the company's balance sheet. Investors also form their own opinion of VanEck Pharmaceutical's value that differs from its market value or its book value, called intrinsic value, which is VanEck Pharmaceutical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because VanEck Pharmaceutical's market value can be influenced by many factors that don't directly affect VanEck Pharmaceutical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between VanEck Pharmaceutical's value and its price as these two are different measures arrived at by different means. Investors typically determine if VanEck Pharmaceutical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, VanEck Pharmaceutical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.